How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?

Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) with the involvement of immune cells and molecules, including cytokines, chemokines and proteases. A previous extensive review about the molecular biology of matrix metalloproteases (MMPs) and tissue inhibitors of...

Descripción completa

Detalles Bibliográficos
Autores principales: Opdenakker, Ghislain, Vermeire, Séverine, Abu El-Asrar, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509204/
https://www.ncbi.nlm.nih.gov/pubmed/36164340
http://dx.doi.org/10.3389/fimmu.2022.983964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509204/
https://www.ncbi.nlm.nih.gov/pubmed/36164340
http://dx.doi.org/10.3389/fimmu.2022.983964

Ejemplares similares